SCHEDULE: Gagnon Entities Disclose Ownership in Profound Medical Corp.
Ownership Disclosure
Gagnon Securities LLC, Gagnon Advisors, LLC, and Neil Gagnon report their beneficial ownership of Profound Medical Corp. common shares as of December 31, 2024.
Summary
- Gagnon Securities LLC, Gagnon Advisors, LLC, and Neil Gagnon have filed a Schedule 13G disclosing their ownership in Profound Medical Corp.
- Gagnon Securities LLC beneficially owns 1,920,060 shares, representing 6.4% of the class.
- Gagnon Advisors, LLC beneficially owns 896,671 shares, representing 3.0% of the class.
- Neil Gagnon beneficially owns 3,346,743 shares, representing 11.2% of the class.
- These holdings include shares over which they have sole or shared voting and dispositive power.
- The calculations are based on 30,028,476 common shares outstanding as of December 10, 2024.
Sentiment
Score: 7
Explanation: The document is a routine filing and does not indicate any positive or negative sentiment. It is a neutral disclosure of ownership.
Positives
- The filing indicates a significant ownership stake by Gagnon entities in Profound Medical Corp.
- Neil Gagnon's direct ownership and control over a portion of the shares suggests a strong personal investment in the company.
Risks
- The document does not explicitly state any risks, but large ownership stakes can sometimes lead to concerns about potential influence or control.
Industry Context
This filing is a standard disclosure for significant shareholders and is common in the investment industry. It provides transparency about ownership stakes in publicly traded companies.
Comparison to Industry Standards
- Schedule 13G filings are a standard practice for investors who acquire more than 5% of a company's stock.
- The ownership percentages reported by Gagnon entities are within the range of what is typically seen in such filings.
- Similar filings are made by institutional investors and individuals who hold significant positions in publicly traded companies, such as BlackRock, Vanguard, and Fidelity.
Stakeholder Impact
- The disclosure provides transparency to shareholders regarding the ownership structure of Profound Medical Corp.
- The filing may be of interest to other investors and stakeholders who track ownership changes in the company.
Key Dates
| Date | Description |
|---|---|
| 12/10/2024 | Date used to calculate the percentage of beneficial ownership based on the number of outstanding shares. |
| 12/31/2024 | Date of event which requires filing of this statement. |
| 01/23/2025 | Date of filing of the Schedule 13G. |
Keywords
Profound Medical Corp, Gagnon Securities LLC, Gagnon Advisors LLC, Neil Gagnon, beneficial ownership, Schedule 13G, common shares, investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.